Binding and functional profiling of antibody mutants guides selection of optimal candidates as antibody drug conjugates.
An increasingly appreciated conundrum in the discovery of antibody drug conjugates (ADCs) is that an antibody that was selected primarily for strong binding to its cancer target may not serve as an optimal ADC. In this study, we performed mechanistic cell-based experiments to determine the correlati...
Saved in:
| Main Authors: | John C Zwaagstra, Traian Sulea, Jason Baardsnes, Stevo Radinovic, Yuneivy Cepero-Donates, Alma Robert, Maureen D O'Connor-McCourt, Ilia A Tikhomirov, Maria Luz Jaramillo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0226593&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A glyco-engineering approach for site-specific conjugation to Fab glycans
by: Maria L. Jaramillo, et al.
Published: (2023-12-01) -
Sequence-based engineering of pH-sensitive antibodies for tumor targeting or endosomal recycling applications
by: Wanlei Wei, et al.
Published: (2024-12-01) -
Diverse Roles of Antibodies in Antibody–Drug Conjugates
by: Aiko Yamaguchi, et al.
Published: (2025-01-01) -
Antibody drug conjugates
by: Stalin Bala, et al.
Published: (2020-01-01) -
Antibody drug conjugates in the clinic
by: Edidiong Udofa, et al.
Published: (2024-11-01)